title: Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake.
abstract: We studied the biochemical effects of calcium supplementation during a 2-mo course in postmenopausal women (x +/- SD: 64 +/- 5 y of age and 14.5 +/- 6.7 y since menopause). The effects on calcium homeostasis and bone remodeling were assessed after 1 and 2 mo of daily administration of either calcium carbonate (1200 mg elemental Ca/d, n = 60) or a placebo (n = 56). The daily dietary calcium intake assessed before the beginning of calcium supplementation was 786 mg/d. We found a significant inverse relation between baseline intact parathyroid hormone (iPTH) and dietary calcium intake before supplementation (r = -0.48, P = 0.0002). A significant increase in urinary excretion of pyridinoline was observed when the dietary calcium intake was lower than the median value. Calcium supplementation resulted in a significant increase in 24-h urinary calcium (39%, P < 0.02) and a significant reduction of bone alkaline phosphatase at 2 mo and of all bone-resorption markers (hydroxyproline, pyridinoline, and deoxypyridinoline) at I and 2 mo without significant changes in 44-68 PTH fragments or iPTH concentrations. When the dietary calcium intake was low (mean +/- SD: 576 +/- 142 mg/d), calcium supplementation was responsible for a greater increase in urinary calcium excretion and a greater decrease in markers of bone turnover. The greatest variations were observed for deoxypyridinoline at 1 and 2 mo (-18.5%, P < 0.05) and for pyridinoline at 1 mo (-16.3%, P < 0.01). Two months of calcium supplementation in postmenopausal women was efficient in reducing markers of bone turnover, with a greater effect in women with a low dietary calcium intake.
authors.affiliation: Department of Rheumatology, CHU, Amiens, France.
authors.forename: P
authors.initials: P
authors.lastname: Fardellone
authors.forename: M
authors.initials: M
authors.lastname: Brazier
authors.forename: S
authors.initials: S
authors.lastname: Kamel
authors.forename: J
authors.initials: J
authors.lastname: Guéris
authors.forename: A M
authors.initials: AM
authors.lastname: Graulet
authors.forename: J
authors.initials: J
authors.lastname: Liénard
authors.forename: J L
authors.initials: JL
authors.lastname: Sebert
mesh_terms: D000368:Aged; D000596:Amino Acids / Q000652:urine; D016723:Bone Remodeling / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D002136:Calcium, Dietary / Q000378:metabolism* / Q000652:urine; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D005260:Female; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D017698:Postmenopause / Q000378:metabolism*; D014807:Vitamin D / Q000378:metabolism
chemical_list: D000596:Amino Acids; D002136:Calcium, Dietary; D010281:Parathyroid Hormone; D014807:Vitamin D; C015484:pyridinoline; D002118:Calcium